Page 119 - TD-4-3
P. 119

Tumor Discovery                                                             Radiation oncologists in AI era



            anatomical  accuracy  still  remain  key  areas  for  further   ensure informed consent for AI use, and respect patients’
            research and standardization. The generative adversarial   rights to refuse AI-based interventions. In addition, the
            networks algorithm has shown promise in generating   environmental impact of AI systems, including energy
            clearer, more detailed synthetic images, offering an   consumption and e-waste, must be considered. 16,17
            advantage in image clarity compared to traditional   In conclusion, AI is expected to play a central role in
            methods. 8,9
                                                               shaping the future of radiation oncology. Personalized
              AI-assisted adaptive  radiotherapy offers significant   treatment protocols,  biomarker-driven  dose adaptation,
            advantages for patients with frequent anatomical changes,   and even fully autonomous treatment planning may
            such as those with head and neck, lung, or gynecological   become the norm. However, strong ethical oversight, legal
            cancers.  Daily  cone  beam  CT  imaging  allows  real-time   frameworks, and sustainable implementation models will
            evaluation, while AI-based auto-contouring enables rapid   be  essential  for this integration. Radiation oncologists
            delineation of tumors and organs at risk. Treatment plans   will need not only medical expertise but also a solid
            can  be  updated  instantly  based  on  anatomical  shifts.   understanding of AI technologies. As the field evolves, the
            However, limitations such as suboptimal image quality and   focus will shift from technical tasks to clinical decision-
            the need for expert validation of AI-generated contours   making and patient-centered care, making it essential for
            highlight the continued importance of human oversight in   radiation oncologists to redefine their roles and actively
            clinical decision-making. 10                       integrate into multidisciplinary care teams to remain
              Prognostic estimations in radiation oncology have   indispensable in an increasingly automated landscape.
            traditionally relied on clinical and anatomical data.
            However, AI-based models now enable more precise   Conflict of interest
            predictions by integrating biological, clinical, dosimetric,   The author declares that she has no conflict of interest.
            treatment, and imaging data. 11,12  Toxicity prediction is
            equally crucial for developing personalized treatment   References
            plans, minimizing both acute and late side effects, and   1.   Wang L, Chen X, Zhang L, et al. Artificial intelligence in
            ultimately improving patient quality of life. 13,14  Predictive   clinical decision support systems for oncology. Int J Med Sci.
            models, especially those using hybrid approaches,     2023;20(1):79-86.
            combine  radiomic/dosiomic  features  with  clinical  and
            dosimetric parameters to improve both prognosis and      doi: 10.7150/ijms.77205
            toxicity prediction. Challenges include ensuring clinically   2.   Nafees A, Khan M, Chow R,  et al. Evaluation of clinical
            acceptable model accuracy, ensuring data diversity, and   decision support systems in oncology: An updated
            navigating regulatory requirements, such as Food and   systematic review. Crit Rev Oncol Hematol. 2023;192:104143.
            Drug Administration approval.                         doi: 10.1016/j.critrevonc.2023.104143
              As AI continues to reshape the landscape of radiation   3.   Erden MB, Cansiz S, Caki O,  et al. FourierLoss: Shape-
            oncology, it is clear that the role of the radiation oncologist   aware l function with Fourier descriptors. Neurocomputing.
            will evolve.  With AI automating routine tasks, clinicians   2025;638:130155.
                     15
            are expected to focus more on patient monitoring and      doi: 10.1016/j.neucom.2025.130155
            complex decision-making. This shift necessitates new
            competencies, including understanding AI algorithms,   4.   Chen M, Wu S, Zhao W, Zhou Y, Zhou Y, Wang G.
            interpreting data, and considering ethical implications.   Application of deep learning to auto-delineation of
                                                                  target volumes and organs at risk in radiotherapy. Cancer
            Radiation oncologists will need to collaborate with   Radiother. 2022;26(3):494-501.
            multidisciplinary teams and develop skills in data literacy
            and clinical validation of AI tools.                  doi: 10.1016/j.canrad.2021.08.020
              As AI becomes increasingly integrated into radiation   5.   Matoska T, Patel M, Liu H, Beriwal S. Review of deep
            oncology, several ethical challenges must be addressed.   learning based autosegmentation for clinical target volume:
                                                                  Current status and future directions.  Adv  Radiat  Oncol.
            These include ensuring patient privacy through data   2024;9(5):101470.
            anonymization and cybersecurity, defining accountability
            in AI-assisted clinical decisions, and mitigating bias arising      doi: 10.1016/j.adro.2024.101470
            from  non-representative  training datasets. Equitable   6.   Wang TW, Hong JS, Huang JW, Liao CY, Lu CF, Wu YT.
            access to AI tools is a concern, as is the potential erosion   Systematic review and meta-analysis of deep learning
            of physicians’ decision-making autonomy. It is crucial   applications in computed tomography lung cancer
            to maintain a strong patient–physician relationship,   segmentation. Radiother Oncol. 2024;197:110344.


            Volume 4 Issue 3 (2025)                        111                           doi: 10.36922/TD025200039
   114   115   116   117   118   119   120   121   122